mps-1 program
Generic: human α-L-iduronidase
mps-1 program: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sigilon Therapeutics, Inc. (SGTX) | Preclinical |
Get deeper analysis on mps-1 program
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis